Selected Publications

Vainstein S, Chan J, March ME, Luo M, Conlin L, Glessner J, Li D, Kao C, Harr M, Menello C, Ahrens-Nicklas RC, Rand EB, Zackai EH, Guay Woodford L, Wang K, Gold JI, Gold NB, Strong A.: The Need for Clinical Diagnostic Proficiency in the Genomic Era. Pediatrics. 21, Aug 2026 Notes: Epub ahead of print. doi:10.1542/peds.2026-076450.

Hölscher DL, Schmitz NEJ, Niggemeier L, Pilva P, Strauch M, Tesar V, Barratt J, Roberts ISD, Coppo R, Barisoni L, Yanagita M, Alabalik U, Rule AD, Jagtap JM, Abreu ES, Seikrit C, von Stillfried S, Taal MW, Kalra PA, Floege J, Kramann R, Boor P, Bülow RD; VALIGA investigators; CureGN investigators; NURTuRE academic steering group; AI4IgAN study group.: Individualised treatment effects of corticosteroids in IgA nephropathy. EBioMedicine. 130, Jul 2026 Notes: doi: 10.1016/j.ebiom.2026.106396.Epub ahead of print.

Dahl NK, August P, Besse W, Chebib FT, Chonchol M, Cowley BD Jr, Goral S, Guay-Woodford LM, Gulati A, Hogan MC, Lakhia R, Miskulin D, Nowak KL, Rahbari-Oskoui F, Park M, Seliger S, Yu A, Watnick T.: KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Am J Kidney Dis. 87(4): 447-507, Apr 2026 Notes: doi: 10.1053/j.ajkd.2025.11.006.

Li Z, Haycraft CJ, Croyle MJ, Hudson D, Yuan Y, Simanyi K, Vendrame HC, Wang J, Kachwala AI, Ma Y, Parant JM, Chumley P, Zhou J, Mrug M, Parnell SC, Tran PV, Gao H, Qian F, Outeda P, Wallace DP, Watnick TJ, Yoder BK; PKD Research Resource Consortium.: A HaloTag Knock-In Resource for In Vivo and In Vitro Analysis of Endogenous Polycystin-2 Localization, Turnover, and Transport. J Am Soc Nephrol. Feb 2026 Notes: Epub ahead of print. doi: 10.1681/ASN.0000001036.

Yang C, Harafuji N, Watts JA, Tao B, Moran C, Clements J, Price K, Laucevicius A, Burrill N, Gebb J, Soni S, Oliver E, Savla JJ, Christ L, Moldenhauer J, Hartung EA, Didier R, Santani A, Sandford RN, Selkirk L, Radley JA, Mann K, Simonicova I, Karl R, Kariat Ashraf AP, Wachten D, Wilson L, Bebok Z, Caldovic L, Guay-Woodford LM.: Disruption of the human cystin-1 myristoyl-electrostatic switch causes polycystic kidney disease that phenocopies autosomal recessive polycystic kidney disease. Kidney Int. Feb 2026 Notes: Available online 18 February 2026. doi: 10.1016/j.kint.2026.01.023.

Huang Y, Xing H, Osouli A, Guay-Woodford L, Chung EJ.: Investigation of Urinary Extracellular Vesicles as Novel and Safe Therapeutics for Autosomal Recessive Polycystic Kidney Disease (ARPKD). J Biomed Mater Res A. 114(2): e70047, Feb 2026 Notes: doi: 10.1002/jbma.70047.

Viteri B, Morales-Tisnés T, Logan J, Zee J, Kaplan S, Back SJ, Hartung EA, Pradhan M, Guay-Woodford L, Furth SL, Amaral S, Tasian GE, Otero HJ.: US-derived Pediatric Kidney Length and Volume Percentiles by Age: A Big Data Approach. Radiol Artif Intell. 8(1): e250056, Jan 2026 Notes: doi: 10.1148/ryai.250056.

Gulati A, Caldovic L, Guay-Woodford LM.: Fibrocystin/polyductin (FPC): new functional insights into ARPKD pathogenesis revealed by informatics, comparative genomics, and model systems. Pediatr Nephrol. Jan 2026 Notes: doi: 10.1007/s00467-025-07129-x.Epub ahead of print.

Salcedo-Giraldo J, Wink KR, Dadzie N, Freiman A, Pyle T, Gordish-Dressman H, Moxey-Mims M, Dahl NK, Guay-Woodford LM, Gulati A; Inherited and Polycystic Kidney Disease (IPKD) Program at Children's National Hospital, Washington, DC. : Structured Application of Genetic Testing in a Pediatric Kidney Clinic. J Am Soc Nephrol. 37(1): 120-130, Jan 2026 Notes: doi:10.1681/ASN.0000000816.Epub 2025 July 29.

Soyfer B, Fedeles S, Ruyle W, Hoover E, Liebau MC, Hartung EA, Dell KM, Guay-Woodford LM, Perrone RD, Oberdhan D.: Qualitative Analysis and Comparison of Externally Led Patient-Focused Drug Development Concepts for Autosomal Recessive Polycystic Kidney Disease Against SONG Initiatives. Kidney Med. 7(11): 101110, Sep 2025 Notes: doi:10.1016/j.xkme.2025.101110.